Skip to main content
INKON Life Technology Co., Ltd. logo

INKON Life Technology Co., Ltd. — Investor Relations & Filings

Ticker · 300143 ISIN · CNE100000XF6 Shenzhen Stock Exchange Manufacturing
Open in API
Filings indexed 2,851 across all filing types
Latest filing 2020-09-17 Board/Management Inform…
Country CN China
Listing Shenzhen Stock Exchange 300143

About INKON Life Technology Co., Ltd.

https://www.inkonlife.com

INKON Life Technology Co., Ltd. specializes in the development and manufacture of advanced medical equipment and digital healthcare solutions. The company focuses on two primary sectors: radiotherapy equipment and digital medical services. Its core product portfolio includes high-precision radiotherapy systems, such as the Gamma Knife, and medical infusion systems. INKON Life leverages Internet of Things (IoT) technology to provide integrated digital hospital solutions, aiming to improve clinical efficiency and patient outcomes. The company serves oncology centers and medical institutions by providing comprehensive cancer treatment solutions and smart healthcare management platforms. By combining medical engineering with digital innovation, INKON Life focuses on the modernization of radiotherapy and the digital transformation of healthcare delivery.

Recent filings

Filing Released Lang Actions
第五届董事会第一次会议决议公告
Board/Management Information Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the first meeting of the fifth board of directors of 盈康生命科技股份有限公司, including election and appointment of the chairman, vice chairman, board committees, general manager, deputy general managers, financial director, board secretary, and securities affairs representative. It includes voting results and detailed biographies of the appointed directors and senior management. The content focuses on changes and appointments in the company's board and senior management, which aligns with the category for announcements of changes in the company's board of directors or senior management. There is no indication that this is a full annual report, audit report, earnings release, or other financial report. The document is not a report publication announcement or a regulatory filing of a different nature. Therefore, the appropriate classification is Board/Management Information (MANG). The document length and detail support a high confidence in this classification.
2020-09-17 Chinese
2020年第三次临时股东大会决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a detailed announcement of the resolutions passed at the 2020 third extraordinary general meeting of shareholders of 盈康生命科技股份有限公司. It includes information about the meeting's convening, attendance, voting results on various proposals including board elections, amendments to the articles of association, and legal opinions on the meeting's validity. The content focuses on the official voting results and decisions made by shareholders at the meeting. There is no indication that this is a full annual report, financial report, or management discussion. The document is not a mere announcement of a report publication but a full disclosure of voting outcomes. Therefore, it fits the category of Declaration of Voting Results & Voting Rights Announcements (DVA). The document length and detail support this classification with high confidence.
2020-09-14 Chinese
2020年第三次临时股东大会的法律意见书
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a legal opinion letter issued by Guangdong Xinda Law Firm regarding the legality of the convening and procedures of the 2020 third extraordinary shareholders' meeting of Yingkang Life Technology Co., Ltd. It details the convening, attendance, voting procedures, and results of the shareholders' meeting, including election of board members and approval of various proposals. The document is not the meeting materials themselves, nor is it a simple announcement of the meeting or voting results. Instead, it is a legal opinion on the shareholders' meeting process and results. This type of document aligns with the category of Declaration of Voting Results & Voting Rights Announcements (DVA), as it officially reports the voting results and validates the meeting's legality. The document length (6481 characters) and detailed content support this classification rather than a brief announcement or a full annual report or management report. Therefore, the appropriate classification is DVA with high confidence.
2020-09-14 Chinese
关于召开2020年第三次临时股东大会的提示性公告
Proxy Solicitation & Information Statement Classification · 95% confidence The document is a detailed announcement about the convening of the 2020 third extraordinary general meeting of shareholders for 盈康生命科技股份有限公司. It includes information about the meeting date, voting procedures (both onsite and online), agenda items including election of board members and supervisory board members, proposal codes, registration methods, and proxy voting instructions. There is no financial data or results reported, nor is it a transcript or presentation. It is not a report publication announcement since it contains substantive details about the meeting itself, not just a notice of report availability. The document is clearly an announcement related to the shareholder meeting and the voting process, but it does not contain the actual voting results. Therefore, it fits best into the category of Declaration of Voting Results & Voting Rights Announcements (DVA) if it contained results, but since it is a notice about the meeting and voting process before the meeting, it is more accurately classified as a Proxy Solicitation & Information Statement (PSI) because it provides materials sent to shareholders to inform and request votes for the meeting.
2020-09-10 Chinese
关于使用闲置募集资金及自有资金进行现金管理的进展公告
Capital/Financing Update Classification · 95% confidence The document is an announcement from a company regarding the progress of using idle raised funds and own funds for cash management. It details amounts invested, counterparties, risk controls, and compliance with stock exchange rules. The document is relatively short (2768 characters) and does not contain financial statements or comprehensive financial data. It is an update on financing activities related to cash management products, not a full financial report or earnings release. Therefore, it fits best under Capital/Financing Update (CAP).
2020-09-09 Chinese
安信证券股份有限公司关于公司2020年上半年度跟踪报告
Interim / Quarterly Report Classification · 90% confidence The document is titled as a "2020 年上半年度跟踪报告" (2020 first half-year tracking report) issued by a sponsoring securities company (安信证券股份有限公司) regarding 盈康生命科技股份有限公司. It includes detailed sections on sponsorship work overview, company issues and measures, shareholder commitments, and other matters. The content is a comprehensive report covering a half-year period with substantive information about company governance, compliance, and financial oversight. The document length is 2112 characters, which is relatively short but contains detailed substantive content rather than just an announcement or certification. The nature of the report aligns with an Interim / Quarterly Report (IR) as it covers a period shorter than a full fiscal year and includes substantive data and analysis. It is not an announcement of a report publication, nor a certification or regulatory filing. Therefore, the best classification is Interim / Quarterly Report (IR). H1 2020
2020-09-07 Chinese

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.